Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
暂无分享,去创建一个
D. Tousoulis | G. Siasos | A. Briasoulis | C. Sohrabi | C. Bakogiannis | N. Papageorgiou | E. Androulakis | B. Saberwal | S. Ahsan
[1] D. Choi,et al. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction , 2020, Heart.
[2] B. Borlaug. Evaluation and management of heart failure with preserved ejection fraction , 2020, Nature Reviews Cardiology.
[3] J. García-Fernández,et al. Biomarkers in atrial fibrillation and heart failure with non-reduced ejection fraction: Diagnostic application and new cut-off points. , 2020, Heart & lung : the journal of critical care.
[4] P. Ponikowski,et al. How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) , 2020, European journal of heart failure.
[5] Kazuhiro Yamamoto,et al. Differential Prognostic Impact of Atrial Fibrillation in Hospitalized Heart Failure Patients With Preserved Ejection Fraction According to Coronary Artery Disease Status - Report From the Japanese Nationwide Multicenter Registry. , 2020, Circulation journal : official journal of the Japanese Circulation Society.
[6] N. Takahashi,et al. Catheter ablation of atrial fibrillation reduces heart failure rehospitalization in patients with heart failure with preserved ejection fraction , 2020, Journal of cardiovascular electrophysiology.
[7] Jacob P. Kelly,et al. Rhythm Control Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: Insights From Get With The Guidelines—Heart Failure , 2019, Journal of the American Heart Association.
[8] J. Spertus,et al. Comparison of the Effect of Catheter Ablation for Atrial Fibrillation on All-Cause Hospitalization in Patients With Versus Without Heart Failure (from the Nationwide Readmission Database). , 2019, The American journal of cardiology.
[9] K. Aonuma,et al. Relationships between maintenance of sinus rhythm and clinical outcomes in patients with heart failure with preserved ejection fraction and atrial fibrillation. , 2019, Journal of cardiology.
[10] Snehal R. Patel,et al. Efficacy of Catheter Ablation of Atrial Fibrillation in Heart Failure with Preserved Ejection Fraction , 2019, Journal of Cardiac Failure.
[11] G. Hindricks,et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial , 2019, JAMA.
[12] J. Brachmann,et al. Atrial fibrillation ablation strategies and outcome in patients with heart failure: insights from the German ablation registry , 2019, Clinical Research in Cardiology.
[13] M. Diez,et al. Atrial Fibrillation in Heart Failure Patients with Preserved or Reduced Ejection Fraction. Prognostic significance of Rhythm control strategy with Catheter Ablation. , 2019, Journal of atrial fibrillation.
[14] H. Hachiya,et al. Impact of catheter ablation of atrial fibrillation on long-term clinical outcomes in patients with heart failure. , 2018, Journal of cardiology.
[15] F. Brozovich,et al. HFpEF, a Disease of the Vasculature: A Closer Look at the Other Half , 2018, Mayo Clinic proceedings.
[16] Timothy M. Markman,et al. Catheter ablation versus conventional treatment of atrial fibrillation in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials , 2018, Journal of Interventional Cardiac Electrophysiology.
[17] J. P. Piccini,et al. Mineralocorticoid Receptor Antagonism for the Treatment of AF and HFpEF: Preserving Hope. , 2018, JACC. Heart failure.
[18] S. Saksena,et al. Atrial resynchronization therapy in patients with atrial fibrillation and heart failure with and without systolic left ventricular dysfunction: a pilot study , 2018, Journal of Interventional Cardiac Electrophysiology.
[19] R. Ochani,et al. Atrial fibrillation and heart failure- results of the CASTLE-AF trial , 2018, Journal of community hospital internal medicine perspectives.
[20] M. Yoshiyama,et al. Prevalence and Prognostic Significance of Functional Mitral and Tricuspid Regurgitation Despite Preserved Left Ventricular Ejection Fraction in Atrial Fibrillation Patients. , 2018, Circulation journal : official journal of the Japanese Circulation Society.
[21] M. Ishihara,et al. Left atrial ejection force predicts the outcome after catheter ablation for paroxysmal atrial fibrillation , 2018, Journal of cardiovascular electrophysiology.
[22] Kevin L. Thomas,et al. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction. , 2017, Heart rhythm.
[23] Deepak L. Bhatt,et al. Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. , 2017, Journal of the American College of Cardiology.
[24] P. Ponikowski,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.
[25] Sanjiv J. Shah,et al. Spironolactone for Management of Heart Failure with Preserved Ejection Fraction: Whither to After TOPCAT? , 2015, Current Atherosclerosis Reports.
[26] K. Aonuma,et al. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction. , 2013, Journal of the American College of Cardiology.
[27] M. O'Neill,et al. Catheter ablation of atrial fibrillation in heart failure. , 2013, Heart failure clinics.
[28] D. Packer,et al. Success of Ablation for Atrial Fibrillation in Isolated Left Ventricular Diastolic Dysfunction: A Comparison to Systolic Dysfunction and Normal Ventricular Function , 2011, Circulation. Arrhythmia and electrophysiology.
[29] Mendel Suchmacher,et al. Systematic reviews and meta-analyses , 2019, Practical Biostatistics.
[30] Dick Menzies. Systematic reviews and meta-analyses. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[31] D. Callans,et al. Atrial Fibrillation and Heart Failure: Treatment Considerations for a Dual Epidemic , 2009, Circulation.
[32] C. Schneider,et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. , 2008, European heart journal.
[33] K. Dickstein,et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. , 2007, European heart journal.
[34] A. Goette,et al. Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation. , 2001, The American journal of cardiology.
[35] T. Zolotarova,et al. PREDICTORS OF ATRIAL FIBRILLATION RECURRENCE AFTER RADIOFREQUENCY ABLATION IN PATIENTS WITH CHRONIC HEART FAILURE. , 2021, Wiadomosci lekarskie.